Event Brief
AstraZeneca in talks with Bristol Myers Squibb on megadeal
Filed: Aug 02, 2026 at 5:00 PM ET
Summary: AstraZeneca is considering a merger with Bristol Myers Squibb in talks over a $400 billion deal.
WHO: AstraZeneca
WHAT: Considering a merger with Bristol Myers Squibb in talks over a $400 billion megadeal
WHEN: Aug 02, 2026 at 4:12 PM ET
WHERE: UK
WHY: Cause not yet established.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →